Nu Skin Enterprises, Inc.
NUS
$12.13
$0.756.59%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -11.79% | -11.85% | -12.04% | -11.37% | -9.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -11.79% | -11.85% | -12.04% | -11.37% | -9.70% |
| Cost of Revenue | -7.13% | -5.61% | -6.36% | -23.84% | -5.57% |
| Gross Profit | -13.69% | -14.29% | -14.22% | -6.08% | -11.28% |
| SG&A Expenses | -14.11% | -12.90% | -12.27% | -9.33% | -9.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.97% | -10.71% | -10.51% | -13.91% | -8.05% |
| Operating Income | -8.88% | -28.28% | -33.03% | 30.53% | -30.33% |
| Income Before Tax | 175.49% | -417.40% | -758.63% | -359.39% | -430.57% |
| Income Tax Expenses | 331.43% | -118.32% | -258.24% | 72.14% | 68.67% |
| Earnings from Continuing Operations | 167.92% | -1,063.13% | -1,805.57% | -276.34% | -311.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 167.92% | -1,063.13% | -1,805.57% | -276.34% | -311.81% |
| EBIT | -8.88% | -28.28% | -33.03% | 30.53% | -30.33% |
| EBITDA | -11.02% | -21.32% | -21.48% | 21.12% | -20.21% |
| EPS Basic | 167.96% | -1,080.00% | -1,795.46% | -275.43% | -310.33% |
| Normalized Basic EPS | 39.40% | -27.91% | -41.23% | 31.00% | -42.43% |
| EPS Diluted | 167.13% | -1,004.01% | -1,860.20% | -278.35% | -313.80% |
| Normalized Diluted EPS | 39.35% | -27.84% | -40.98% | 32.03% | -42.16% |
| Average Basic Shares Outstanding | 0.06% | 0.07% | -0.10% | -0.27% | -0.37% |
| Average Diluted Shares Outstanding | 0.36% | 0.21% | -0.44% | -0.71% | -0.82% |
| Dividend Per Share | -73.33% | -80.49% | -84.62% | -63.34% | -41.94% |
| Payout Ratio | 1.39% | 0.98% | -1.01% | -1.21% | -1.27% |